Delaying Treatment of Ocular Hypertension: The Ocular Hypertension Treatment Study
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To compare the safety and efficacy of earlier vs later treatment in preventing primary open-angle glaucoma (POAG) in individuals with ocular hypertension. METHODS: One thousand six hundred thirty-six individuals with intraocular pressure (IOP) from 24 to 32 mm Hg in 1 eye and 21 to 32 mm Hg in the fellow eye were randomized to observation or to topical ocular hypotensive medication. Median time of treatment in the medication group was 13.0 years. After a median of 7.5 years without treatment, the observation group received medication for a median of 5.5 years. To determine if there is a penalty for delaying treatment, we compared the cumulative proportions of participants who developed POAG at a median follow-up of 13 years in the original observation group and in the original medication group. MAIN OUTCOME MEASURES: Cumulative proportion of participants who developed POAG. RESULTS: The cumulative proportion of participants in the original observation group who developed POAG at 13 years was 0.22 (95% confidence interval [CI], 0.19-0.25), vs 0.16 (95% CI, 0.13-0.19) in the original medication group (P = .009). Among participants at the highest third of baseline risk of developing POAG, the cumulative proportion who developed POAG was 0.40 (95% CI, 0.33-0.46) in the original observation group and 0.28 (95% CI, 0.22-0.34) in the original medication group. There was little evidence of increased adverse events associated with medication. APPLICATION TO CLINICAL PRACTICE: Absolute reduction was greatest among participants at the highest baseline risk of developing POAG. Individuals at high risk of developing POAG may benefit from more frequent examinations and early preventive treatment. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00000125.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Racial Differences in the Cause-Specific Prevalence of Blindness in East Baltimore
Sommer, A., Tielsch, J. M., Katz, J., Quigley, H. A., Gottsch, J. D., Javitt, J. C., Martone, J. F., Royall, R. M., Witt, K. A., & Ezrine, S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111143252004 · Cited by 764 · cited 1×
“It is also the leading cause of blindness among individuals of African origin.(2,6-9) Furthermore, there is increasing evidence that glaucoma is more prevalent in some groups of Hispanic Americans.”
Prevalence of open-angle glaucoma and ocular hypertension in Latinos
Varma, R., Ying-Lai, M., Francis, B. A., Nguyen, B. B.-T., Deneen, J., Wilson, M. R., & Azen, S. P. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.01.025 · Cited by 483
Self-citation
Cited by
De Moraes, C. G., Liebmann, J. M., & Levin, L. A. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.10.001 · Cited by 203
“)(Kass et al., 2010).”
Why Do People (Still) Go Blind from Glaucoma?
Susanna, R., De Moraes, C. G., Cioffi, G. A., & Ritch, R. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.2.1 · Cited by 198
“Kass et al.84 proposed that OHT individuals at high risk of developing OAG may benefit from more frequent examinations and early preventive treatment.”
Surveillance for ocular hypertension: an evidence synthesis and economic evaluation.
Burr, J., Botello-Pinzon, P., Takwoingi, Y., Hernández, R., Vazquez-Montes, M., Elders, A., Asaoka, R., Banister, K., van der Schoot, J., Fraser, C., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16290 · Cited by 180
Metadata
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-03-01
- Volume
- 128
- Issue
- 3
- Pages
- 276
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W2140758530
- Cited by
- 172
- References
- 2
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delaying Treatment of Ocular Hypertension: The Ocular Hypertension Treatment Study. https://app.cochat.ai/papers/10.1001/archophthalmol.2010.20
- The paper
- Delaying Treatment of Ocular Hypertension: The Ocular Hypertension Treatment Study. (2010). Archives of Ophthalmology. https://doi.org/10.1001/archophthalmol.2010.20
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.